Marmier, Solenne
Inserm · Sorbonne Université
4 papers on CoChatORCID 0000-0002-6671-0940
Most cited papers
- Verified
Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration
Meliani, A., Boisgerault, F., Hardet, R., Marmier, S., Collaud, F., Ronzitti, G., Leborgne, C., Costa Verdera, H., Simon Sola, M., Charles, S., et al. (2018) · Nature Communications
Virus-based gene therapy researchRNA Interference and Gene Delivery
Cited by 265
- Verified
A Specific ChREBP and PPARα Cross-Talk Is Required for the Glucose-Mediated FGF21 Response
Iroz, A., Montagner, A., Benhamed, F., Levavasseur, F., Polizzi, A., Anthony, E., Régnier, M., Fouché, E., Lukowicz, C., Cauzac, M., et al. (2017) · Cell Reports
Fibroblast Growth Factor ResearchPeroxisome Proliferator-Activated Receptors
Cited by 128
- Verified
Enhanced liver gene transfer and evasion of preexisting humoral immunity with exosome-enveloped AAV vectors
Meliani, A., Boisgerault, F., Fitzpatrick, Z., Marmier, S., Leborgne, C., Collaud, F., Simon Sola, M., Charles, S., Ronzitti, G., Vignaud, A., et al. (2017) · Blood Advances
Virus-based gene therapy researchRNA Interference and Gene Delivery
Cited by 127
- Verified
Exposure to wild-type AAV drives distinct capsid immunity profiles in humans
Kuranda, K., Jean-Alphonse, P., Leborgne, C., Hardet, R., Collaud, F., Marmier, S., Costa Verdera, H., Ronzitti, G., Veron, P., & Mingozzi, F. (2018) · Journal of Clinical Investigation
Virus-based gene therapy researchImmunotherapy and Immune Responses
Cited by 104
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free